JB Chemicals & Pharmaceuticals Limited — Updates, 16-01-2026: Press Release
16-01-2026 | 06:15 pm
16-01-2026 | 06:15 pm
JB Pharma reported strong Q3 FY26 results: Revenue up 11% to 1065 Cr, EBITDA up 13% to 305 Cr, Net Profit surged 22% to 198 Cr. Domestic formulations outperformed market growth. International and CDMO segments showed robust performance, improving margins.
No comments yet. Be the first to comment!
All announcements from JB Chemicals & Pharmaceuticals Limited
